Literature DB >> 18604195

A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.

Agnieszka Rybak1, Heiko Fuchs, Lena Smirnova, Christine Brandt, Elena E Pohl, Robert Nitsch, F Gregory Wulczyn.   

Abstract

miRNA populations, including mammalian homologues of lin-4 (mir-125) and let-7, undergo a marked transition during stem-cell differentiation. Originally identified on the basis of their mutational phenotypes in stem-cell maturation, mir-125 and let-7 are strongly induced during neural differentiation of embryonic stem (ES) cells and embryocarcinoma (EC) cells. We report that embryonic neural stem (NS) cells express let-7 and mir-125, and investigate post-transcriptional mechanisms contributing to the induction of let-7. We demonstrate that the pluripotency factor Lin-28 binds the pre-let-7 RNA and inhibits processing by the Dicer ribonuclease in ES and EC cells. In NS cells, Lin-28 is downregulated by mir-125 and let-7, allowing processing of pre-let-7 to proceed. Suppression of let-7 or mir-125 activity in NS cells led to upregulation of Lin-28 and loss of pre-let-7 processing activity, suggesting that let-7, mir-125 and lin-28 participate in an autoregulatory circuit that controls miRNA processing during NS-cell commitment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604195     DOI: 10.1038/ncb1759

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  403 in total

1.  The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche.

Authors:  Hila Toledano; Cecilia D'Alterio; Benjamin Czech; Erel Levine; D Leanne Jones
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

Review 2.  Small RNAs have a big impact on regeneration.

Authors:  Elizabeth J Thatcher; James G Patton
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 3.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

4.  Molecular basis for interaction of let-7 microRNAs with Lin28.

Authors:  Yunsun Nam; Casandra Chen; Richard I Gregory; James J Chou; Piotr Sliz
Journal:  Cell       Date:  2011-11-10       Impact factor: 41.582

5.  LIN28B promotes colon cancer progression and metastasis.

Authors:  Catrina E King; Miriam Cuatrecasas; Antoni Castells; Antonia R Sepulveda; Ju-Seog Lee; Anil K Rustgi
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

6.  Characterization and expression of lin-28a involved in lin28/let-7signal pathway during early development of P. olivaceus.

Authors:  Yuanshuai Fu; Lina Gao; Zhiyi Shi; Feng You; Junling Zhang; Wenjuan Li
Journal:  Fish Physiol Biochem       Date:  2017-12-07       Impact factor: 2.794

Review 7.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

8.  miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain.

Authors:  Dominique Cannella; Marie-Pierre Brenier-Pinchart; Laurence Braun; Jason M van Rooyen; Alexandre Bougdour; Olivier Bastien; Michael S Behnke; Rose-Laurence Curt; Aurélie Curt; Jeroen P J Saeij; L David Sibley; Hervé Pelloux; Mohamed-Ali Hakimi
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 9.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.

Authors:  Ezinne Francess Mong; Kemal Marc Akat; John Canfield; John Lockhart; Jeffrey VanWye; Andrew Matar; John C M Tsibris; June K Wu; Thomas Tuschl; Hana Totary-Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.